NuCana plc — Investor Relations & Filings
Filings indexed
269
across all filing types
Latest filing
2026-05-14
Regulatory Filings
Country
GB
United Kingdom
Listing
US
NCNA
NuCana plc is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. The company utilizes its proprietary ProTide technology, a phosphoramidate chemistry platform, to develop a portfolio of new anti-cancer medicines. This technology is designed to generate more effective and safer therapies by overcoming key cancer cell resistance mechanisms that often limit the efficacy of widely prescribed chemotherapy agents. NuCana's pipeline includes novel drug candidates, such as NUC-7738, which are being evaluated for a broad range of cancers, both as standalone treatments and in combination with other therapies like immunotherapy.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2026-05-14 | English | |
| 6-K - NuCana plc (0001709626) (Filer) | 2026-05-06 | English | |
| 3 - NuCana plc (0001709626) (Issuer) | 2026-03-24 | English | |
| 3 - NuCana plc (0001709626) (Issuer) | 2026-03-20 | English | |
| 3 - NuCana plc (0001709626) (Issuer) | 2026-03-19 | English | |
| S-8 - NuCana plc (0001709626) (Filer) | 2026-03-19 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 46280918 | 6-K | 2026-05-14 | English | ||
| 42006907 | 6-K - NuCana plc (0001709626) (Filer) | 2026-05-06 | English | ||
| 33035056 | 3 - NuCana plc (0001709626) (Issuer) | 2026-03-24 | English | ||
| 33002157 | 3 - NuCana plc (0001709626) (Issuer) | 2026-03-20 | English | ||
| 32990022 | 3 - NuCana plc (0001709626) (Issuer) | 2026-03-19 | English | ||
| 32989857 | S-8 - NuCana plc (0001709626) (Filer) | 2026-03-19 | English | ||
| 32980615 | SCHEDULE 13D - NuCana plc (0001709626) (Subject) | 2026-03-18 | English | ||
| 32979865 | 3 - NuCana plc (0001709626) (Issuer) | 2026-03-18 | English | ||
| 32979844 | 3 - NuCana plc (0001709626) (Issuer) | 2026-03-18 | English | ||
| 32979820 | 3 - NuCana plc (0001709626) (Issuer) | 2026-03-18 | English | ||
| 32979885 | 3 - NuCana plc (0001709626) (Issuer) | 2026-03-18 | English | ||
| 13044500 | 6-K | 2026-01-06 | English | ||
|
2025
3 filings
| |||||
| 13044501 | 6-K | 2025-12-17 | English | ||
| 13044502 | 6-K | 2025-12-10 | English | ||
| 13044506 | 6-K | 2025-11-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
NuCana plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35327/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35327 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35327 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35327 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35327}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NuCana plc (id: 35327)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.